AnnaBPawlowskaMD

Pediatric Hematology & Oncology • Duarte, CA

Professor, Director, Pediatric Hematopoietic Stem Cell Transplant program at City of Hope

Join to view full profile

Dr. Pawlowska is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pawlowska's full profile

Already have an account?

Office
1500 Duarte Rd
Duarte, CA 91010
Phone+1 626-359-8111

Fax+1 626-218-5310

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1995 - 1998
University of ColoradoResidency, Pediatrics, 1992 - 1995
University of Medical Science PoznanClass of 1985

Certifications & Licensure

CA State Medical License 1999 - 2025
MN State Medical License 1996 - 2000
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia Start of enrollment: 2009 Nov 01
Withdrawn
Not Applicable
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
ACTIVE_NOT_RECRUITING
PHASE3
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
COMPLETED
Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma Start of enrollment: 2013 Jul 01
Withdrawn
Not Applicable
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Completed
Phase 2
Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease Start of enrollment: 2018 Feb 02
RECRUITING
PHASE1
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) Start of enrollment: 2017 Nov 28
COMPLETED
PHASE2
Roles: Principal Investigator, Contact
Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03
COMPLETED
Roles: Principal Investigator, Contact
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease Start of enrollment: 2022 Jul 13
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Reducing learning and psychosocial disparities in Latino children with cancer: a randomized intervention trial.
Sunita K Patel, Seong-Hyeon Kim, Kathleen Ingman, Van Huynh, Heather Huszti
Journal of the National Cancer Institute. 2025-03-01
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy.
Ibrahim Aldoss, Haoyue Shan, Dongyun Yang, Mary C Clark, Monzr Al Malki
Transplantation and Cellular Therapy. 2024-08-01
Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, ...
Corinna La Rosa, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Teodora Kaltcheva
Haematologica. 2024-07-01

Abstracts/Posters

Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identif...
Anna B Pawlowska, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019